Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target.
Cancer Commun (Lond)
; 42(2): 164-169, 2022 02.
Article
in En
| MEDLINE
| ID: mdl-34862750
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Proteomics
Limits:
Humans
Language:
En
Journal:
Cancer Commun (Lond)
Year:
2022
Document type:
Article